Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

PURPOSE: Radiation therapy (RT) improves control of Hodgkin lymphoma (HL), but patients who undergo RT are at risk for late effects, including cardiovascular disease and second cancers, because of radiation doses to organs at risk (OARs). Proton therapy (PT) can reduce OAR doses compared with conven...

Descripción completa

Detalles Bibliográficos
Autores principales: Ntentas, Georgios, Dedeckova, Katerina, Andrlik, Michal, Aznar, Marianne C., George, Ben, Kubeš, Jiří, Darby, Sarah C., Cutter, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493042/
https://www.ncbi.nlm.nih.gov/pubmed/30708133
http://dx.doi.org/10.1016/j.prro.2019.01.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493042/
https://www.ncbi.nlm.nih.gov/pubmed/30708133
http://dx.doi.org/10.1016/j.prro.2019.01.006

Ejemplares similares